in Australia the trademarked supplement ingredient dynamine (methylliberine) is considered to be a prohibited stimulant, but such substances are not yet targeted in the scope of WADA drug testing
S., Berwick, M., Halpern, A
Rat full-thickness wounds (6mm diameter, 13-day study) treated with GHK showed 64.5% reduction in wound size compared to 45.6% for vehicle-treated and 28.2% for control group, accompanied by significantly lower TNF- and elastin-degrading MMPs
The metabolism and clearance of both components may be affected by significant liver disease, and patients with severe hepatic impairment should be monitored closely if treatment is deemed necessary
N., Chen, X., Dobrovolskaia, M